Table 2.
Clinical and imaging indicators of subjects at different time points.
| Controls (n=34) | Patients W1 (n=34) | Patients W4 (n=34) | Patients W12 (n=34) | |
|---|---|---|---|---|
| FMA (0–100) | – | 51.315±9.209 | 73.355±8.854** | 89.703±7.870**,*** |
| Barthel index (0–100) | – | 54.732±12.937 | 77.708±8.634** | 86.368±14.409**,*** |
| Interhemispheric FC | 1.01±0.043 | 0.587±0.119* | 0.929±0.077*,** | 0.969±0.093*,**,*** |
| FA in ipsilesional CST | 0.547±0.058 | 0.448±0.029* | 0.492±0.033*,** | 0.544±0.045**,*** |
| FA in contralesional CST | 0.547±0.058 | 0.538±0.055 | 0.544±0.048 | 0.548±0.040 |
FA – fractional anisotropy; FMA – Fugl-Meyer Assessment; FC – functional connectivity. The FA of healthy controls were derived from averages of bilateral CST measurements.
*
Compared with the control group, P<0.05 obtained by two-sample independent t tests;
**
compared with week 1, P<0.05 obtained by RM-ANOVA;
***
compared with week 4, P<0.05 obtained by RM-ANOVA.